HIV New Product Introduction Toolkit

The purpose of this guidance from EGPAF is to aid health care workers and support caregivers and children initiated on, or switched to,...

In mid-2021, national HIV programmes began to transition treatment for children living with HIV to dolutegravir (DTG) 10 ...

The WHO Pediatric ARV dosing dashboard aims to support health care workers, researchers and policy makers in decisions around ARV dosing...

A compilation of recently published WHO guidelines, including CHAI briefs on these guidelines. 2021 WHO Consolidated Guidelines on HIV...

This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal...

These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new...

A how-to guide for implementing weight-based ART monitoring for improving pediatric treatment optimization outcomes. This guide, in...

In March 2021, the WHO published new clinical and service delivery recommendations for HIV prevention, treatment, and care. In April, the...

This sixth edition of the Optimal Formulary and Limited-use List supports the transition to optimal WHO-recommended ART regimens for...

WHO published guidelines on the management of advanced HIV disease in 2017, promoting a package of interventions to prevent, identify and...

This memo highlights the patient benefits, cost savings and improved supply security associated with proactively switching eligible 2L...

CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...

This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside...